Form 8-K - Current report:
SEC Accession No. 0001493152-24-039011
Filing Date
2024-10-01
Accepted
2024-10-01 15:55:19
Documents
20
Period of Report
2024-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 56202
2 ex1-1.htm EX-1.1 73853
3 ex4-1.htm EX-4.1 113970
4 ex4-2.htm EX-4.2 115284
5 ex5-1.htm EX-5.1 16251
6 ex10-1.htm EX-10.1 269884
7 ex99-1.htm EX-99.1 12273
  Complete submission text file 0001493152-24-039011.txt   974056

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE aim-20240930.xsd EX-101.SCH 3015
9 XBRL LABEL FILE aim-20240930_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE aim-20240930_pre.xml EX-101.PRE 24166
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3564
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-27072 | Film No.: 241343076
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)